Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- Harvard University
- Nature Careers
- University of Maryland, Baltimore
- Indiana University
- University of Cincinnati
- Centro de Investigação em Psicologia (CIPsi)
- Cold Spring Harbor Laboratory
- East Tennessee State University
- Eisbach Bio GmbH
- Genentech
- Queen's University Belfast
- University of Kansas Medical Center
- 2 more »
- « less
-
Field
-
the laboratory and core facilities (https://www.vai.org/research/core-services/ ). Research emphasis on cell-type specific toxicities, neuron-glia interactions, genetics and epigenetics will provide insights in
-
training in biomedical sciences, preferably in immunology, metabolism, cancer biology, epigenetics or microbiology. We are looking for an experienced and highly motivated scientist to join a collaborative
-
to bear on the work in the lab. The successful candidate will work with Dr. David Sinclair to develop an independent research project within the scope of the lab’s focus on aging, genetics, and epigenetic
-
project investigating the interplay between epigenetics and metabolism in embryonic stem cells (ESCs). Metabolic pathways supply essential metabolites for chemical modifications of chromatin, ultimately
-
. The successful candidate will work with Dr. David Sinclair to develop an independent research project within the scope of the lab's focus on aging, genetics, and epigenetic reprogramming. In addition to carrying
-
epigenetics or/and experience in working on embryonic/adult stem cells and cancer cell lines are a plus. The Somyajit lab, based at Department of Biochemistry and Molecular Biology , SDU, has a deep interest in
-
and most concentrated centers of science, engineering, and medicine in the United States. Further information on SDB can be found at https://sdbri.org. Position Overview San Diego BioMed (SDB) is
-
Medical Center is focused on unraveling the epigenetic mechanisms involved in vascular dysfunction associated with cardiopulmonary complications, with a current emphasis on understanding how Obstructive
-
), Jeffrey Fredberg (bioengineering, cell migration in asthma and cancer), Bernardo Lemos (epigenetics, genomics, aging, nucleolus), Quan Lu (asthma, pyroptosis, GPCR signaling, extracellular vesicles
-
epigenetics and genome stability to develop innovative small-molecule inhibitors that target specific vulnerabilities in cancer cells. We discover new inhibitors for our target enzymes using allosteric